Evidence map›Paper›PMID 30363777›Full record

ArticleCancer nanotechnology2018

Magnetic hyperthermia of breast cancer cells and MRI relaxometry with dendrimer-coated iron-oxide nanoparticles.

Marzieh Salimi, Saeed Sarkar, Reza Saber, Hamid Delavari, Ali Mohammad Alizadeh, Hendrik Thijmen Mulder

Abstract read
In one paragraph

Article in Cancer nanotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Nanoparticle-Mediated Hyperthermia and Cytotoxicity Mechanisms in Cancer.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Magnetic Nanoparticles in Cancer Therapy and Diagnosis.Advanced healthcare materials · 2020
    Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marzieh Salimi1Department of Medical Physics and Biomedical Engineering, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, P.O. Box 1417613151, Iran.ORCID 0000-0002-8426-5975
Saeed Sarkar1Department of Medical Physics and Biomedical Engineering, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, P.O. Box 1417613151, Iran.
Reza Saber2Research Center for Science and Technology in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Hamid Delavari4Department of Materials Science and Engineering, Tarbiat Modares University, Tehran, Iran.
Ali Mohammad Alizadeh5Cancer Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Hendrik Thijmen Mulder6Department of Radiation Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.ORCID 0000-0003-2165-8840

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, some studies have focused on dendrimer nanopolymers as a magnetic resonance imaging (MRI) contrast agent or a vehicle for gene and drug delivery. Considering the suitable properties of these materials, they are appropriate candidates for coating iron-oxide nanoparticles which are applied in magnetic hyperthermia. To the best of our knowledge, the novelty of this study is the investigation of fourth-generation dendrimer-coated iron-oxide nanoparticles (G

methodsIONPs were synthesized via co-precipitation and coated with the fourth generation (G

resultsThe TEM results showed that G

conclusionsOur results encouraged the future application of G4@IONPs in magnetic hyperthermia and MR imaging.

Indexed as

Breast cancerDendrimerIron-oxide nanoparticlesMagnetic hyperthermiaMRI

Identifiers

PMID30363777
PMCPMC6182570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.